Lv52
1038 积分 2023-04-18 加入
Use of Dulaglutide, Semaglutide, and Tirzepatide in Diabetes and Weight Management
5小时前
已完结
Risk of Suicide, Hair Loss, and Aspiration with GLP1-Receptor Agonists and Other Diabetic Agents: A Real-World Pharmacovigilance Study
1天前
已完结
Mazdutide Versus Dulaglutide for Weight Loss and Diabetes Management: Meta-Analysis of Randomized Clinical Trials
6天前
已完结
过氧化物酶体增殖物激活受体(PPAR)在肝脏疾病中的作用及潜在意义
7天前
已完结
急性冠状动脉综合征合并糖尿病共病的研究进展
8天前
已关闭
The challenge of weight loss maintenance in obesity: a review of the evidence on the best strategies available
11天前
已完结
Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity
11天前
已完结
Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial
11天前
已完结
Body-mass index and obesity in urban and rural China: findings from consecutive nationally representative surveys during 2004–18
11天前
已完结
Soft Drinks, Fruit Juices, and Energy Drinks
14天前
已完结
皖公网安备34019202002308
